herpes zoster oticus newsletter

Herpes zoster oticus (HZ oticus) is a viral infection of the inner, middle, and external ear. A result of reactivation of varicella-zoster virus infection, it manifests as severe otalgia and associated cutaneous vesicular eruption.

Also called Ramsay Hunt Syndrome or Ramsay Hunt Syndrome type II, it is a common complication of shingles. Herpes Zoster Oticus, also known as Ramsay Hunt Syndrome Type II, is a rare but serious neurological disorder caused by the reactivation of the varicella-zoster virus (VZV), the same virus that causes chickenpox and shingles. When VZV reactivates in the geniculate ganglion of the facial nerve (cranial nerve VII), it can result in this painful and potentially debilitating condition.

DelveInsight, through its newsletter series, aims for increased awareness about the indication, its underlying causes, etiology, symptoms, and risk factors among its readers.

The newsletter is a brief introduction of the indication – Herpes zoster oticus, with its epidemiological analysis, treatment approaches, unmet needs in the market, and upcoming therapies in the pipeline.

The newsletter also provides market scenario, key pharma companies in the Herpes zoster oticus market, and key collaborations, partnerships along with top conferences.

Fill up the form to gain access of the newsletter. Subscribe to our series for more such deep and rich insights into the pharma market.

Join DelveInsight's emailer list and gain a competitive edge